Skip to main content
Log in

FOBT should be first choice for colorectal cancer in Asia

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Tsoi KKF, Ng SSM, Leung MCM, Sung JJY.Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia. Alimentary Pharmacology and Therapeutics 28: 353-363, No. 3, 1 Aug 2008

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

FOBT should be first choice for colorectal cancer in Asia. Pharmacoecon. Outcomes News 562, 7 (2008). https://doi.org/10.2165/00151234-200805620-00014

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805620-00014

Keywords

Navigation